Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,000
Closed -$1.45M 4156
2019
Q3
$1.45M Buy
+10,000
New +$1.49M ﹤0.01% 2597
2019
Q2
Sell
-6,000
Closed -$768K 3855
2019
Q1
$768K Sell
6,000
-6,100
-50% -$718K ﹤0.01% 2755
2018
Q4
$1.29M Buy
12,100
+4,200
+53% +$469K ﹤0.01% 2485
2018
Q3
$904K Buy
+7,900
New +$893K ﹤0.01% 2755

Other funds holding STE

David Shaw's STE Position: Q2 2026 in Review

David Shaw increased its Steris (STE) stake by 189% in Q2 2026, buying an estimated $71.5M and bringing the position to 509,610 shares worth $107M. The position accounts for 0.05% of the portfolio, ranked #422.

David Shaw first reported a position in STE in Q2 2013 and has held it in 35 quarters since. 828 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • David Shaw held 509,610 shares of Steris worth $107M as of Q2 2026.
  • David Shaw bought 333,453 Steris shares in Q2 2026, an estimated $71.5M.
  • Steris made up 0.05% of David Shaw's portfolio in Q2 2026, its #422 holding.
  • David Shaw first reported a position in Steris in Q2 2013 and has held it in 35 quarters since.
  • 828 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.